Clinical profile and outcomes of patients with clinical benign prostate hyperplasia treated by trans urethral resection of prostate at Bugando Medical Centre, Mwanza, Tanzania

George Elisamehe  Mocha; Bartholomeo Nicholaus  Ngowi; John Zakayo  Igenge; Willium Rhys  Mahalu; Frank Kora  Chacha; Frank James  Kiwara; Hamisi Ganja  Matalu; Andrea Joseph  Mombo; Benson Richard  Kidenya

doi:10.30574/gscbps.2021.15.3.0125

Authors

George Elisamehe Mocha Department of urology, Bugando Medical Centre, Mwanza, Tanzania.
Bartholomeo Nicholaus Ngowi Department of urology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
John Zakayo Igenge Department of urology, Catholic University of Health and Allied Sciences (CUHAS), Mwanza Tanzania.
Willium Rhys Mahalu Department of general surgery, Bugando Medical Centre, Mwanza, Tanzania.
Frank Kora Chacha Department of urology, Catholic University of Health and Allied Sciences (CUHAS), Mwanza Tanzania.
Frank James Kiwara Department of urology, Catholic University of Health and Allied Sciences (CUHAS), Mwanza Tanzania.
Hamisi Ganja Matalu Department of urology, Bugando Medical Centre, Mwanza, Tanzania.
Andrea Joseph Mombo Department of urology, Bugando Medical Centre, Mwanza, Tanzania.
Benson Richard Kidenya Department of Biochemistry, Catholic University of Health and Allied Sciences (CUHAS), Mwanza, Tanzania.

DOI:

https://doi.org/10.30574/gscbps.2021.15.3.0125

Keywords:

Clinical Benign prostatic hyperplasia, Transurethral resection of prostate, Lower urinary tract symptoms, International prostate symptoms scores

Abstract

Introduction: Benign Prostate Hyperplasia (BPH) is the most common prostatic pathology in elderly men with Trans Urethral Resection of the Prostate (TURP) still being considered as the gold standard surgical management. TURP is the commonest endoscopic surgery performed for BPH in developing countries including Tanzania, however its outcome in this part of the world has not been documented. Therefore, the study aimed to determine the clinical profile, outcome as well as predictors of outcome in patients with clinical BPH undergoing TURP at Bugando Medical Centre (BMC), a tertiary hospital in Mwanza, Tanzania.

Methods: This was a cross sectional longitudinal hospital based study to evaluate the clinical profile as well as the outcome of patients with clinical BPH treated by TURP at BMC from November 2018 to April 2019. All participants scheduled for TURP for the diagnosis of clinical BPH who signed informed consent for the study were included, their international prostate symptom score (IPSS) with the 8^thquestion for quality of life (QoL) was scored, social demographic data and clinical profile information were obtained from their files. Participants were followed in the theatre to document any intraoperative complications and other necessary data required by this study.

Progress in the ward was recorded and following discharge, patient was scheduled for follow up at 6 and 12 weeks. During follow up, IPSS and QoL scores as well as complication was recorded.

Results: A total of 210 participants met the eligibility criteria. The median age was 69 (IQR 63-75) years. Prostate size ranged from 15 – 200 grams with median size of 77 (IQR 51-107) grams. Acute urine retention was the most common indication 69 (33%), followed by lower urinary tract symptoms 52 (25%). Urologist operated most of the patient 122 (58.1%) with the rest operated by either resident alone or finished up by urologist, and the median weight resected was 20 (IQR 13.5 –28.3) grams. About 66 (31.4%) developed perioperative complication with majority having clot retention. During follow up, the median IPSS score was 9 (IQR 7 – 12) and 2 (IQR 0 – 6) and median QoL score of 3 (IQR 1 – 3) and 0 (IQR 0 – 1) with improvement of 93 (45.4%) and 184 (89.8%) on 1^st and 2^nd follow up visits respectively. There were a total of 9 (4.3%) patients whom developed Trans urethral resection (TUR) syndrome, with overall mortality of 3 (1.4%).

Conclusion: BPH is common from 6^th decade of life onwards. Though most participants were operated because of either acute urine retention or severe lower urinary tract symptoms (LUTS), some presents late already with renal insufficiency. Despite the fact that most of the participants had severe symptoms and their quality of life was poor at presentation, TURP improved symptoms in most of the participants. The improvement is even better in the hands of experienced surgeon, for the participants with small prostate and in absence of UTI prior to surgery.

Metrics

Metrics Loading ...

References

Wein AJ, Louis RK, Alan WP, Craig P. Campbell-Walsh Urology. 11th ed. Elsevier Inc.; 2016. 6928–6961.

Kyprianou N, Tu H, Jacobs SC. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol. 1996; 27(7): 668–75.

Liu C-C, Huang S-P, Chou Y-H, Wang C-J, Huang C-H. Current indications for transurethral resection of the prostate and associated complications. Kaohsiung J Med Sci. 2003; 19(2): 49–54.

Briganti A, Capitanio U, Suardi N, Gallina A, Salonia A, Bianchi M, et al. Benign Prostatic Hyperplasia and Its Aetiologies. Eur Urol Suppl. 2009; 8(13): 865–71.

Srinivasan B, Radhakrishnan R. Prospective Study on Removal of Urethral Catheter on Post Op Day 2 Vs Conventional Day 4 after Turp. IOSR J Dent Med Sci Ver IV. 2015;14(5):2279–861.

Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivizatos G, et al. Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int. 2012; 109(2): 240–8.

Souverein PC, Erkens JA, De la Rosette JJMCH, Leufkens HGM, Herings RMC. Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Urol. 2003; 43(5): 528–34.

Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatichyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology. 1991; 38(1 SUPPL.): 4–8.

McVary KT. Clinical evaluation of benign prostatic hyperplasia. Rev Urol. 2003; 5 (Suppl. 4): S3–11.

Jang DG, Yoo C, Oh CY, Kim SJ, Kim S Il, Kim C Il, et al. Current status of transurethral prostatectomy: A korean multicenter study. Korean J Urol. 2011; 52(6): 406–9.

Yucel M, Aras B, Yalcinkaya S, Kemal Hatipoglu N, Aras E. Conventional monopolar transurethral resection of prostate in patients with large prostate (≥80 grams). Cent Eur J Urol. 2013; 66(3): 303–8.

Bozdar HR, Memon SR, Paryani JP. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia. J Ayub Med Coll Abbottabad. 2010; 22(4): 194–6.

Persu C, Georgescu D, Arabagiu I, Cauni V, Moldoveanu C, Geavlete P. TURP for BPH. How large is too large? J Med Life. 2010; 3(4): 376–80.

Nnabugwu II, Ugwumba FO, Udeh EI OO. Learning Transurethral Resection of the Prostate: A Comparison of the Weight of Resected Specimen to the Weight of Enucleated Specimen in Open Prostatectomy. Niger J Clin Pract. 2018; 20(1590): 5.

Antunes AA, Srougi M, Coelho RF, Leite KR, Freire GDC. Transurethral Resection of the Prostate for the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia : How Much Should Be Resected ? 2009; 35(6): 683–91.

Soleimani M, Hoseini SY, Aliasgari M, Dadkhah F, Lashay A, Amini E. Long-term outcome of Trans Urethral Prostatectomy in benign prostatic hyperplasia patients with and without diabetes mellitus. J Pakistan Med Assoc. 2010;60(2):109–12.

George C, Haque PD, Mammen KJ. Incidence, clinical manifestations and outcome of TUR (transurethral resection) syndrome in patients undergoing TURP under spinal anaesthesia: results from clinical observations in a cohort of 50 patients at a tertiary care centre in North India. Int Surg J. 2017; 5(1): 243.

Chukwujama N, Oguike T, Azike J. Transurethral resection of the prostate a 3 year experience. Niger J Surg. 2011;17(1):15.

Alhasan SU, Aji SA, Mohammed AZ, Malami SS. Transurethral resection of the prostate in Northern Nigeria, problems and prospects. BMC Urol. 2008; 8(1).

Al-Singary W, Arya M, Patel HRH. Bladder neck stenosis after transurethral resection of prostate: does size matter?. Urol Int. 2004; 73(3): 262–5.

Kallenberg F, Hossack TA, Woo HH. Long-term followup after electrocautery transurethral resection of the prostate for benign prostatic hyperplasia. Adv Urol. 2011(3):359478 doi: 10.1155/2011/359478. Epub 2011 Nov 28. PMID: 22162679; PMCID: PMC3227243.

Yamane T. Statistics : an introductory analysis. 2nd ed. New York: Harper and Row; 1967.

Gunda D, Kido I, Kilonzo S, Nkandala I, Mpondo B. Prevalence and Associated Factors of Incidentally Diagnosed Prostatic Carcinoma among Patients Who Had Transurethral Prostatectomy in Tanzania : A Retrospective Study. Ethiop J Heal Sci. 2017;28(1):11.

Mteta K, Musau P, Keiza N. Blood Transfusion in Transurethral Resection of the Prostate (TURP): A Practice that Can be Avoided. East Cent African J Surg. 2012;17(2):102–7

Swai A, Nyongole O V, Mteta AK. A one year trend of blood loss during transurethral resection of the prostate as seen at urology department , Kilimanjaro Christian Medical Center in Moshi , Tanzania : Do we avoid unnecessary blood transfusion. 2016; 2(6): 150–4.

Rajeev R, Giri B, Choudhary LOKP, Kumar R. Surgery for benign prostatic hyperplasia : Profile of patients in a tertiary care institution. 2017; 30(1)7–10.

Kumar A, Shiwach DK. Trans Urethral Resection of Prostate for Symptomatic BPH in Rural Area. Int J Anatomy,Radiology Surg. 2016;5(1):16–9.

Joshi HN, De Jong IJ, Karmacharya RM, Shrestha B, Shrestha R. Outcomes of transurethral resection of the prostate in benign prostatic hyperplasia comparing prostate size of more than 80 grams to prostate size less than 80 grams. Kathmandu Univ Med J. 2014; 12(47): 163–7.

Eziyi AK, Olajide AO, Asafa OQ, Ayomide OO, Oyeniyi AG, Ojewuyi O. Preliminary experience with Monopolar Transurethral Resection of Prostate ( TURP ). IOSR J Dent Med Sci. 2017;16(8):16–21.

Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol. 1999; 162(4): 1307–10.

Young MJ, Elmussareh M, Morrison T, Wilson JR. The changing practice of transurethral resection of the prostate. Ann R Coll Surg Engl. 2018; 100(4): 326–9.

Balzarro M, Ficarra V, Bartoloni A, Tallarigo C, Malossini G. The Pathophysiology, Diagnosis and Therapy of the Transurethral Resection of the Prostate Syndrome. Urol Int. 2001;66:121–6.

Hawary A, Mukhtar K, Sinclair A, Pearce I. Transurethral Resection of the Prostate Syndrome : J Endourol. 2020;23(12):2013–20.

Schout BMA, Persoon MC, Martens EJ, Bemelmans BLH, Scherpbier AJJA, Hendrikx AJM. Analysis of Pitfalls Encountered by Residents in Transurethral Procedures in Master-Apprentice Type of Training. J Endourol. 2010; 24(4): 621–8.

Dissayabutra T, Ungjaroenwathana W, Bunyaratavej C, Prasopsanti K, Tosukhowong P. Irrigation with water during transurethral resection of the prostate (TURP) induces intravascular hemolysis. Asian Biomed. 2013;7(6):795–802.

Yousef AA, Suliman GA, Elashry OM, Elsharaby MD, Elgamasy AE naser K. A randomized comparison between three types of irrigating fluids during transurethral resection in benign prostatic hyperplasia. BMC Anesthesiol. 2010;10:7–13.

Braeckman J, Denis L. Management of BPH then 2000 and now 2016 – From BPH to BPO. Asian Journal of Urology. 2017; 4(3); 138–47.

Eredics K, Wachabauer D, Röthlin F, Madersbacher S, Schauer I. Reoperation Rates and Mortality After Transurethral and Open Prostatectomy in a Long-term Nationwide Analysis: Have We Improved Over a Decade? Urology. 2018; 118: 152–7. Doi: 10.1016/j.urology.2018.04.032. Epub 2018 May 4. PMID: 29733869.

García-villa PC, Schroede-ugalde M, Soler-martín ML, Mendoza-peña F. Original article Risk factors for developing urethral stricture in patients that underwent transurethral resection of the prostate. Rev Mex Urol. 2013;73(4):166–74.

Bhageria A, Nayak B, Rai PK, Dogra PN. Post TURP obliterative urethral stricture: Unusual presentation and favourable result. African J Urol. 2013;19(2):78–81.

Suhani, Gupta S, Gupta A, Saha S, Mahapatra L, Srivastava UK. Outcome of surgery for benign prostatic hyperplasia-is it predictable? J Clin Diagnostic Res. 2013; 7(12): 2859–62.